New Needle-Free Nasal Spray Approved for Childhood Allergies
新型無針鼻噴劑獲批用於治療兒童過敏症
更新於: 2026年6月13日 上午06:45
For millions of families managing severe allergies, the emergency "EpiPen" has long been a source of stress.
對於數百萬管理嚴重過敏的家庭來說，緊急「EpiPen」長期以來一直是壓力的來源。
Many parents and patients fear needles, leading to dangerous delays in treatment.
許多家長和患者害怕針頭，導致治療出現危險的延誤。
Fortunately, a medical breakthrough is changing the landscape of allergy care: neffy, the first needle-free epinephrine nasal spray.
幸運的是，一項醫學突破正在改變過敏照護的格局：neffy，這是首款無針腎上腺素鼻噴劑。
Approved by the FDA and the MHRA, this pocket-sized device delivers life-saving epinephrine directly into the nostril, even if the patient is congested.
該裝置已獲得美國食品藥物管理局（FDA）和英國藥品及保健品管理局（MHRA）的批准，能將救命的腎上腺素直接輸送到鼻孔中，即使患者鼻塞也能使用。
The device is designed for ease of use; human factor studies show that even children as young as ten can administer it confidently.
該裝置專為易用性而設計；人為因素研究顯示，即使是十歲的兒童也能自信地進行操作。
Importantly, this is an emergency rescue medication, meaning that after use, one must still seek immediate medical attention.
重要的是，這是一種緊急救援藥物，這意味著使用後仍必須尋求即時的醫療護理。
